ELUT Elutia Inc

  1. Stocks
  2. Healthcare
  3. NASDAQ: ELUT

Price (delayed)

$2.93

Market cap

$71.12M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$2.07

Enterprise value

$92.9M

aziyo was created by highcape partners and tissue banks international with the mission of restoring health and mobility to the greatest number of patients. our vision for aziyo is to ...

Highlights
ELUT's quick ratio is up by 33% since the previous quarter and by 6% year-on-year
ELUT's EPS is up by 13% YoY
Elutia's revenue has decreased by 31% from the previous quarter but it has increased by 3.8% YoY
ELUT's gross margin is up by 22% since the previous quarter but it is down by 8% year-on-year
ELUT's equity is down by 31% QoQ
The company's gross profit fell by 16% QoQ and by 5% YoY
Sector: Healthcare
Industry: Medical Devices
Website: http://aziyobio.com
Peers: NVCR NVAX

Key stats

What are the main financial stats of ELUT
Market
Shares outstanding
24.27M
Market cap
$71.12M
Enterprise value
$92.9M
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
N/A
Price to sales (P/S)
2.15
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
3.75
Earnings
Revenue
$24.75M
EBIT
-$31.83M
EBITDA
-$28.08M
Free cash flow
-$22.11M
Per share
EPS
-$2.07
Free cash flow per share
-$1.22
Book value per share
-$1.66
Revenue per share
$1.36
TBVPS
$1.75
Balance sheet
Total assets
$43.43M
Total liabilities
$82.03M
Debt
$41.05M
Equity
-$38.6M
Working capital
-$11.78M
Liquidity
Debt to equity
-1.06
Current ratio
0.73
Quick ratio
0.52
Net debt/EBITDA
-0.78
Margins
EBITDA margin
-113.5%
Gross margin
44.7%
Net margin
-152.2%
Operating margin
-123.4%
Efficiency
Return on assets
-71.4%
Return on equity
N/A
Return on invested capital
-128.4%
Return on capital employed
-8,141.2%
Return on sales
-128.6%
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

ELUT stock price

How has the Elutia stock price performed over time
Intraday
3.9%
1 week
5.78%
1 month
-5.18%
1 year
20.08%
YTD
35.65%
QTD
-7.28%

Financial performance

How have Elutia's revenue and profit performed over time
Revenue
$24.75M
Gross profit
$11.05M
Operating income
-$30.53M
Net income
-$37.66M
Gross margin
44.7%
Net margin
-152.2%
Elutia's net margin has plunged by 62% from the previous quarter and by 10% YoY
The operating margin has declined by 37% since the previous quarter but it rose by 16% year-on-year
Elutia's revenue has decreased by 31% from the previous quarter but it has increased by 3.8% YoY
ELUT's gross margin is up by 22% since the previous quarter but it is down by 8% year-on-year

Growth

What is Elutia's growth rate over time

Valuation

What is Elutia stock price valuation
P/E
N/A
P/B
N/A
P/S
2.15
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
3.75
ELUT's EPS is up by 13% YoY
ELUT's equity is down by 31% QoQ
The P/S is 115% more than the last 4 quarters average of 1.0
Elutia's revenue has decreased by 31% from the previous quarter but it has increased by 3.8% YoY

Efficiency

How efficient is Elutia business performance
ELUT's ROS has plunged by 67% from the previous quarter and by 11% YoY
The ROIC has plunged by 51% YoY and by 41% from the previous quarter
ELUT's return on assets is down by 32% year-on-year and by 25% since the previous quarter

Dividends

What is ELUT's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for ELUT.

Financial health

How did Elutia financials performed over time
The total assets is 47% smaller than the total liabilities
The company's current ratio fell by 39% YoY and by 16% QoQ
The total assets has declined by 37% year-on-year and by 20% since the previous quarter
Elutia's debt to equity has soared by 86% YoY and by 26% from the previous quarter
ELUT's equity is down by 31% QoQ

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.